BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 24530145)

  • 21. Early hospital discharge of infants born to group B streptococci-positive mothers: a decision analysis.
    Berger MB; Xu X; Williams JA; Van de Ven CJ; Mozurkewich EL
    BJOG; 2012 Mar; 119(4):439-48. PubMed ID: 22251453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Do we need a different approach to GBS screening?].
    Szymusik I; Kosińska-Kaczyińska K; Pietrzak B; Wielgoś M
    Ginekol Pol; 2014 Jun; 85(6):456-60. PubMed ID: 25029812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of Neonatal Group B Sreptococcal Infection. Spanish Recommendations. Update 2012. SEIMC/SEGO/SEN/SEQ/SEMFYC Consensus Document].
    Alós Cortés JI; Andreu Domingo A; Arribas Mir L; Cabero Roura L; de Cueto López M; López Sastre J; Melchor Marcos JC; Puertas Prieto A; de la Rosa Fraile M; Salcedo Abizanda S; Sánchez Luna M; Sanchez Pérez MJ; Torrejon Cardoso R; ; ; ; ;
    Enferm Infecc Microbiol Clin; 2013 Mar; 31(3):159-72. PubMed ID: 22658283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination.
    Berardi A; Cattelani C; Creti R; Berner R; Pietrangiolillo Z; Margarit I; Maione D; Ferrari F
    Expert Rev Anti Infect Ther; 2015; 13(11):1387-99. PubMed ID: 26295167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk factors for Group B Streptococcus colonization during pregnancy and influences of intrapartum antibiotic prophylaxis on maternal and neonatal outcomes.
    Chen X; Cao S; Fu X; Ni Y; Huang B; Wu J; Chen L; Huang S; Cao J; Yu W; Ye H
    BMC Pregnancy Childbirth; 2023 Mar; 23(1):207. PubMed ID: 36973793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compliance with protocols for prevention of neonatal group B streptococcal sepsis: practicalities and limitations.
    Gilbert GL; Hewitt MC; Turner CM; Leeder SR
    Infect Dis Obstet Gynecol; 2003; 11(1):1-9. PubMed ID: 12839627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects for preventing infant invasive GBS disease through maternal vaccination.
    Madhi SA; Dangor Z
    Vaccine; 2017 Aug; 35(35 Pt A):4457-4460. PubMed ID: 28237500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GBS public awareness, advocacy, and prevention--what's working, what's not and why we need a maternal GBS vaccine.
    Burns G; Plumb J
    Vaccine; 2013 Aug; 31 Suppl 4():D58-65. PubMed ID: 23973348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential cost-effectiveness of a maternal Group B streptococcal vaccine in The Gambia.
    Ahmed N; Giorgakoudi K; Usuf E; Okomo U; Clarke E; Kampmann B; Le Doare K; Trotter C
    Vaccine; 2020 Mar; 38(15):3096-3104. PubMed ID: 32147298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrapartum antibiotics for known maternal Group B streptococcal colonization.
    Ohlsson A; Shah VS
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007467. PubMed ID: 19588432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.
    Jordan HT; Farley MM; Craig A; Mohle-Boetani J; Harrison LH; Petit S; Lynfield R; Thomas A; Zansky S; Gershman K; Albanese BA; Schaffner W; Schrag SJ;
    Pediatr Infect Dis J; 2008 Dec; 27(12):1057-64. PubMed ID: 18989238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrapartum antibiotics for known maternal Group B streptococcal colonization.
    Ohlsson A; Shah VS
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007467. PubMed ID: 23440815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Group B streptococcal epidemiology and vaccine needs in developed countries.
    Melin P; Efstratiou A
    Vaccine; 2013 Aug; 31 Suppl 4():D31-42. PubMed ID: 23973345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.
    Schrag S; Gorwitz R; Fultz-Butts K; Schuchat A
    MMWR Recomm Rep; 2002 Aug; 51(RR-11):1-22. PubMed ID: 12211284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of different prevention strategies on neonatal group B streptococcal disease.
    Vergani P; Patanè L; Colombo C; Borroni C; Giltri G; Ghidini A
    Am J Perinatol; 2002 Aug; 19(6):341-8. PubMed ID: 12357426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapartum antibiotics for known maternal Group B streptococcal colonization.
    Ohlsson A; Shah VS
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007467. PubMed ID: 24915629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Group B streptococcal disease in infants: progress in prevention and continued challenges.
    Verani JR; Schrag SJ
    Clin Perinatol; 2010 Jun; 37(2):375-92. PubMed ID: 20569813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screning study on pregnant women and neonatal infection with streptococcus agalactiae (group B streptococci)].
    Decheva A; Zlatkov V; Pandev K; Ivanova D; Kalev K; Rousseva R; Hitrova-Nikolova S; Hristov R; Shopova E; Milenkova K
    Akush Ginekol (Sofiia); 2013; 52(7):4-7. PubMed ID: 24505632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party.
    Campbell N; Eddy A; Darlow B; Stone P; Grimwood K;
    N Z Med J; 2004 Aug; 117(1200):U1023. PubMed ID: 15475993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.